Laura Moliner

An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer

Ilias Houda, Idris Bahce, Chris Dickhoff et al. · Lung Cancer · 2024 · 50 citations · Full text

Medicine, Oncology, Surgery +10

Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry

Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio et al. · Journal for ImmunoTherapy of Cancer · 2025 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Prognostic factors and effect on survival of immune-related adverse events in patients with non-small-cell lung cancer treated with immune checkpoint blockage

David Conde‐Estévez, Inés Monge‐Escartín, Alejandro Ríos-Hoyo et al. · Journal of Chemotherapy · 2020 · 17 citations

Life Sciences, Immunology, Oncology +17

OA06.03 An International EORTC Survey on Resectability of Stage III Non-small Cell Lung Cancer

Ilias Houda, Idris Bahce, Chris Dickhoff et al. · Journal of Thoracic Oncology · 2023 · 15 citations · Full text

Medicine, Oncology, Surgery +10